Oliver Lagore Vanvalin Investment Group »

Taysha Gene Therapies shares owned by Oliver Lagore Vanvalin Investment Group

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Oliver Lagore Vanvalin Investment Group from 13F filings

Historical chart of Oliver Lagore Vanvalin Investment Group investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Oliver Lagore Vanvalin Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Oliver Lagore Vanvalin Investment Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.6k 2.8k 2.01

More positions owned by Oliver Lagore Vanvalin Investment Group

Spdr S&p 500 Etf (SPY)
Spdr Ser Tr 1 3 hgh yield (BIL)
iShares Lehman 3-7 Yr Treasury Bond (IEI)
iShares Lehman 7-10 Yr Treas. Bond (IEF)
Goldman Sachs Etf Tr aces ultra shr (GSST)
SPDR DJ Wilshire Large Cap (SPLG)
Invesco Nasdaq 100 Etf (QQQM)
Ishares Bitcoin Tr (IBIT)
iShares Lehman 1-3 Year Treas.Bond (SHY)
iShares iBoxx $ High Yid Corp Bond (HYG)
Goldman Sachs Physical Gold (AAAU)
Amazon (AMZN)
J P Morgan Exchange Traded F ultra shrt (JPST)
Fidelity Comwlth Tr ndq cp idx trk (ONEQ)
Microsoft Corporation (MSFT)

View all positions for Oliver Lagore Vanvalin Investment Group

Top funds holding Taysha Gene Therapies

BlackRock
BlackRock
RA Capital Management
VR Adviser
Morgan Stanley
Vanguard Group
Siren
Octagon Capital Advisors
Baker Bros. Advisors
Geode Capital Management
State Street Corporation
Jpmorgan Chase & Co
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding Taysha Gene Therapies